Acadia Pharmaceuticals reported 11.33 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Acadia Pharmaceuticals 11.33 1.25 Jun/2026
ALKERMES 135.81 96.48 Jun/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Biogen 23.23 9.53 Jun/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Cara Therapeutics 0.49 27.28 Mar/2026
Corcept Therapeutics 188.23 74.66 Jun/2026
Eisai 26.55 9.06 Jun/2026
Eli Lilly 32.9 7.37 Jun/2026
Incyte 14.45 0.9 Jun/2026
J&J 29.43 4.9 Jun/2026
Moderna 27.22 14.51 Jun/2023
Neurocrine Biosciences 22.1 5.99 Jun/2026
Pfizer 11.48 2.16 Jun/2026
Prothena 22.11 11.37 Mar/2022
PTC Therapeutics 8.76 1.22 Mar/2026
Sarepta Therapeutics 27.27 0 Mar/2026
Vanda Pharmaceuticals 16.79 7.07 Jun/2023
Vertex Pharmaceuticals 28.05 2.22 Jun/2026